Scarica l'app Stockscreener
7.40
3.57%
-0.31
Precedente Chiudi:
$7.71
Aprire:
$7.71
Volume 24 ore:
30,918
Relative Volume:
0.18
Capitalizzazione di mercato:
$201.89M
Reddito:
$56.13M
Utile/perdita netta:
$-14.67M
Rapporto P/E:
-10.00
EPS:
-0.74
Flusso di cassa netto:
$-9.13M
1 W Prestazione:
-6.12%
1M Prestazione:
+0.34%
6M Prestazione:
+5.61%
1 anno Prestazione:
+85.87%
Intervallo 1D:
$7.42
$7.72
Intervallo di 1 settimana:
$7.42
$8.1139
Portata 52W:
$3.535
$9.40
Journey Medical Corp Stock (DERM) Company Profile
Nome
Journey Medical Corp
Settore
Telefono
480-434-6670
Indirizzo
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Confronta DERM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.44 | 209.22M | 56.13M | -14.67M | -9.13M | -0.74 |
|
ZTS
Zoetis Inc
|
125.41 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.02 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.64 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
490.48 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-30 | Ripresa | B. Riley Securities | Buy |
| 2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
| 2024-06-28 | Ripresa | ROTH MKM | Buy |
| 2021-12-07 | Iniziato | B. Riley Securities | Buy |
Journey Medical Corp Borsa (DERM) Ultime notizie
Fourteen new option listings on November 12th - MSN
Public companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33% - Yahoo Finance
10 Best Travel Insurance Companies For 2026 - Forbes
Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Earnings Beat: Why Profound Medical Corp stock attracts high net worth investorsMarket Trend Review & Risk Controlled Swing Trade Alerts - moha.gov.vn
Aug Weekly: Can Quipt Home Medical Corp. stock reach $100 price targetPortfolio Return Report & Reliable Entry Point Alerts - ulpravda.ru
Journey Medical (NASDAQ:DERM) Trading 2.1% Higher – What’s Next? - Defense World
How Orthofix Medical Inc. stock performs in interest rate cycles2025 Volatility Report & Accurate Entry and Exit Point Alerts - ulpravda.ru
Sheets Smith Investment Management Invests $946,000 in Journey Medical Corporation $DERM - MarketBeat
Is Journey Medical Corporation stock cheap at current valuationWeekly Trade Review & Target Return Focused Stock Picks - Улправда
Journey Medical (NASDAQ:DERM) Trading 2.1% HigherWhat's Next? - MarketBeat
How Journey Medical Corporation stock benefits from tech adoptionWeekly Investment Summary & Smart Allocation Stock Tips - Улправда
Can Zhejiang Taimei Medical Technology Co. Ltd. (A2V) stock ride next bull market cycleMarket Sentiment Summary & Entry Point Confirmation Alerts - Улправда
Can Unidoc Health Corp. (L7T) stock beat analyst consensusJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - Улправда
Is Journey Medical Corporation stock a buy on dipsEarnings Miss & Technical Analysis for Trade Confirmation - Улправда
How analysts rate Quipt Home Medical Corp. stock todayWeekly Gains Report & Accurate Trade Setup Notifications - Улправда
Fortress Biotech (Nasdaq: FBIO): FDA accepts Class 1 resubmission, CUTX-101 PDUFA Jan. 14, 2026 - Stock Titan
Fortress Biotech (NASDAQ: FBIO) extends loan maturity and grants warrants - Stock Titan
Journey Medical announces results from phase 1 trial of DFD-29 - MSN
Layoff Tracker: Pfizer, Geron Downsize To Streamline Costs - BioSpace
Our Products | Full Products and Solutions List | Abbott U.S. - Abbott
Minocycline study shows no microbiome disruption after 16-week use By Investing.com - Investing.com Nigeria
Journey Medical announces results from Phase 1 trial of DFD-29 - TipRanks
DERM FinancialsIncome Statement - Quiver Quantitative
Minocycline study shows no microbiome disruption after 16-week use - Investing.com India
Journey Medical Corporation Reports Positive Phase 1 Trial Results for Emrosi, Meeting All Primary Objectives with No Safety Issues - Quiver Quantitative
Journey Medical (Nasdaq: DERM) posts Phase 1 Emrosi data on 16-week microbiome profile - Stock Titan
Aleen Inc. Introduces Wellness AI: A Journey into Self-Discovery, Not Medical Diagnosis - TradingView — Track All Markets
DERM Stock On The Rise: Worth Watching As Emrosi Adoption Expands - RTTNews
Journey Medical (DERM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Price Action: Why Omega Healthcare Investors Inc. stock attracts high net worth investors2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Published on: 2025-11-27 22:02:05 - moha.gov.vn
Aug Mood: Will Franco Nevada Corporation (3FO) stock outperform global peers2025 Momentum Check & Real-Time Buy Signal Alerts - BỘ NỘI VỤ
Journey Strategic Wealth LLC Takes $250,000 Position in HCA Healthcare, Inc. $HCA - MarketBeat
VITAS Healthcare (CHE) shares caregiver Stacy Noland's hospice-at-home story in new video - Stock Titan
Journey Strategic Wealth LLC Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Envestnet Asset Management Inc. Decreases Holdings in Journey Medical Corporation $DERM - MarketBeat
New VITAS® Healthcare Video Honors Caregiver's Journey and the Power of Hospice at Home - Yahoo Finance
Journey Medical Corp. Experiences Revision in Stock Score Amid Mixed Financial Indicators - Markets Mojo
Head-To-Head Comparison: Dyne Therapeutics (NASDAQ:DYN) versus Journey Medical (NASDAQ:DERM) - Defense World
Analysts Are Bullish on These Healthcare Stocks: Nano-X Imaging (NNOX), Exact Sciences (EXAS) - The Globe and Mail
Will Journey Medical Corporation stock outperform international peersQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Will Journey Medical Corporation stock see insider buyingMarket Growth Report & Low Volatility Stock Recommendations - newser.com
What Makes Journey Medical Corporation (DERM) a Good Investment? - Yahoo! Finance Canada
Detecting price anomalies in Journey Medical Corporation with AIEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
HC Wainwright Forecasts Journey Medical FY2025 Earnings - Defense World
Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Fortress Biotech reports NDA resubmission for Menkes disease treatment - Investing.com
FY2025 EPS Estimates for Journey Medical Reduced by B. Riley - MarketBeat
FY2025 EPS Forecast for Journey Medical Decreased by Analyst - MarketBeat
Journey Medical Corp Azioni (DERM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):